[1]
T. Schlesinger, “Impact of prior treatment in the efficacy and tolerability of tirbanibulin ointment 1% for actinic keratosis: pooled results from two Phase 3 studies”, J of Skin, vol. 6, no. 2, p. s26, Mar. 2022.